09 November 2021: Clinical Research
Association Between Severe Chronic Obstructive Pulmonary Disease and Polyneuropathy
Ahmet Arisoy 1ABCDEF* , Abdullah Yilgor 2BCD , İbrahim H. Uney 1BCDOI: 10.12659/MSM.932690
Med Sci Monit 2021; 27:e932690
Table 1 Characteristics of participants.
| COPD group (n=62) | Control group (n=30) | p-value | |
|---|---|---|---|
| Age (year) | 64.88±8.62 | 62.7±9.65 | .5 |
| FVC (l) | 1.68±0.53 | 2.62±0.72 | .001 |
| %FVC | 53.94±13.17 | 84.20±6.65 | .001 |
| FEV1 (l) | 0.99±0.44 | 2.2±0.56 | .001 |
| %FEV1 | 39.72± 11.96 | 86.30±7.83 | .001 |
| pCO2 (mmHg) | 44.17±9.74 | 36.9±2.51 | .026 |
| CRP (mg/dl) | 12.06±8.42 | 7.12±3.47 | .079 |
| Hemoglobine (g/dl) | 14.7±2.58 | 12.51±2.41 | .023 |
| Creatine (mg/dl) | 0.81±0.17 | 0.96±0.3 | .046 |
| Glucose (mg/dl) | 108.84±20.18 | 95.4±12.87 | .055 |
| Smoking (pack/year) | 38.71±10.18 | 35.75±9.43 | .592 |